American voters soundly rejected Bidenflation at the ballot box. In an ABC exit poll, 67% of Americans said the economy is […]
November 14, 2024 The Honorable Dick Durbin, Chairman United States Senate Committee on the Judiciary 224 Dirksen Senate Office Building […]
(ALEXANDRIA, Virginia) — Consumer Action for a Strong Economy (CASE) today announced the launch of “Goodbye Gary,” a six-figure consumer […]
Welcome back to another edition of Higher Ed on the Hill, where we break down the top issues facing higher […]
For 15 years and counting, the Johnson & Johnson talc litigation saga continues to play out in our nation’s court system, adding […]
“Senator Elizabeth Warren is right” are words rarely spoken in Washington, but they fit, in this case. As Senator […]
For decades, the cost and accessibility of healthcare has been a major issue in federal elections. This year’s race […]
October 21, 2024 Commissioner Robert Califf Food and Drug Administration 10903 New Hampshire Ave Silver Spring, MD 20993 Chair […]
In the wake of the COVID-19 pandemic, the CDC’s role in public health crises remains under enormous scrutiny, especially […]
One wonders whether Kamala Harris will soon be doing endorsements for Nike, given how fast she’s been running away […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/